LIVER TOXICITY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH PAZOPANIB THERAPY

被引:0
|
作者
Lim, F. L. [1 ]
Shamash, J. [2 ]
Wilson, P. [2 ]
Powles, T. [3 ]
机构
[1] St Bartholomews Hosp, Dept Med Oncol, London, England
[2] Barts Canc Insititute, QMUL, London, England
[3] St Bartholomews Hosp QMUL, Barts Canc Inst, London, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:290 / 290
页数:1
相关论文
共 50 条
  • [31] Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma
    Greet Van De Sijpe
    Benoit Beuselinck
    Tine Van Nieuwenhuyse
    Roxanne Poncelet
    Oliver Bechter
    Maarten Albersen
    Eduard Roussel
    Marcella Baldewijns
    Jan Tack
    Isabel Spriet
    [J]. European Journal of Clinical Pharmacology, 2020, 76 : 1273 - 1280
  • [32] Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma
    Van De Sijpe, Greet
    Beuselinck, Benoit
    Van Nieuwenhuyse, Tine
    Poncelet, Roxanne
    Bechter, Oliver
    Albersen, Maarten
    Roussel, Eduard
    Baldewijns, Marcella
    Tack, Jan
    Spriet, Isabel
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (09) : 1273 - 1280
  • [33] Usefulness of Implementing Comprehensive Pharmaceutical Care for Metastatic Renal Cell Carcinoma Outpatients Treated with Pazopanib
    Todo, Maki
    Shirotake, Suguru
    Nishimoto, Koshiro
    Yasumizu, Yota
    Kaneko, Gou
    Kondo, Hideyuki
    Okabe, Takashi
    Makabe, Hideki
    Oyama, Masafumi
    [J]. ANTICANCER RESEARCH, 2019, 39 (02) : 999 - 1004
  • [34] SEQUENTIAL TARGETED THERAPY FOLLOWING PAZOPANIB (PZ) IN PATIENTS (PTS) WITH METASTATIC RENAL CELL CANCER (MRCC): EFFICACY AND TOXICITY
    Pons Valladares, F.
    Choueiri, T. K.
    Hutson, T. E.
    Powles, T. B.
    Porta, C.
    Bracarda, S.
    Lampron, M. E.
    Cerbone, L.
    Sternberg, C. N.
    Bellmunt, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 278 - 278
  • [35] DYNAMIC CHANGES IN PLASMA OSTEOPONTIN AS A MARKERS OF TUMOR RESPONSE IN METASTATIC RENAL CELL CARCINOMA (RCC) PATIENTS TREATED WITH PAZOPANIB
    Tran, H. T.
    Liu, Y.
    Lin, Y.
    Saavedra, A. J. Zurita
    Baker-Neblett, K. L.
    Pandite, L. N.
    Heymach, J. V.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 275 - 276
  • [36] Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Cella, David
    Reeves, James
    Hawkins, Robert
    Guo, Jun
    Nathan, Paul
    Staehler, Michael
    de Souza, Paul
    Merchan, Jaime R.
    Boleti, Ekaterini
    Fife, Kate
    Jin, Jie
    Jones, Robert
    Uemura, Hirotsugu
    De Giorgi, Ugo
    Harmenberg, Ulrika
    Wang, Jinwan
    Sternberg, Cora N.
    Deen, Keith
    McCann, Lauren
    Hackshaw, Michelle D.
    Crescenzo, Rocco
    Pandite, Lini N.
    Choueiri, Toni K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 722 - 731
  • [37] Efficacy and safety of Pazopanib in the treatment of metastatic renal cell carcinoma
    Marmesat Rodas, B.
    Marquez Fernandez, E.
    Quesada Sanz, M. P.
    Guerra Estevez, D.
    Villanueva Jimenez, P.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 572 - 572
  • [38] Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line
    Fiala, Ondrej
    Ostasov, Pavel
    Rozsypalova, Aneta
    Hora, Milan
    Sorejs, Ondrej
    Sustr, Jan
    Bendova, Barbora
    Travnicek, Ivan
    Filipovsky, Jan
    Finek, Jindrich
    Buchler, Tomas
    [J]. TARGETED ONCOLOGY, 2021, 16 (05) : 643 - 652
  • [39] Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line
    Ondřej Fiala
    Pavel Ostašov
    Aneta Rozsypalová
    Milan Hora
    Ondřej Šorejs
    Jan Šustr
    Barbora Bendová
    Ivan Trávníček
    Jan Filipovský
    Jindřich Fínek
    Tomáš Büchler
    [J]. Targeted Oncology, 2021, 16 : 643 - 652
  • [40] Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
    Rossetti, Sabrina
    D'Aniello, Carmine
    Iovane, Gelsomina
    Scagliarini, Sarah
    Laterza, Maria M.
    De Vita, Fernando
    Savastano, Clementina
    Carteni, Giacomo
    Porricelli, Maria A.
    Berretta, Massimiliano
    Pisconti, Salvatore
    Facchini, Gaetano
    Cavaliere, Carla
    [J]. FRONTIERS IN PHARMACOLOGY, 2017, 8